Anteilseigner
Decheng Capital LLC (12,69 %) RA Capital Management LP (7,49 %) Lynx1 Capital Management LP (5,82 %) Great Point Partners LLC (5,65 %) Paradigm BioCapital Advisors LP (4,85 %) Frazier Life Sciences Management LP (4,78 %) BlackRock Fund Advisors (4,20 %) OrbiMed Advisors Private Equity (4,09 %) Alpine Bioventures, GP, LLC (4,01 %) Cormorant Asset Management LP (3,89 %) The Vanguard Group, Inc. (3,29 %) T. Rowe Price Associates, Inc. (Investment Management) (2,54 %) Commodore Capital LP (2,46 %) SSgA Funds Management, Inc. (2,12 %) Octagon Capital Advisors LP (1,89 %) Franklin Advisers, Inc. (1,86 %) Woodline Partners LP (1,53 %) Citadel Securities LLC (1,26 %) Vivo Capital LLC (1,25 %) Geode Capital Management LLC (1,17 %)
Kontakt
ALPINE IMMUNE SCIENCES INC.